KALV FDA approval rallyKALV received FDA approval this week for a new drug, has $220mln in cash, and just bounced off the daily 21EMA (overlayed on this 4H chart).
Recently rejected off the monthly 100ema two times (overlayed on this 4H chart). Breakout beyond the monthly 100ema and first target is $20. Numerous price target increases, most notably, one at $27 and another increased from $32 to $40.
KALV trade ideas
KALH Upside Potential?Looking purely off of KALV with the range that it has been in and the healthcare sector that it is a part of. IF healthcare sector will continue to rebound, this stock could potentially rebound as well back to the $13-$15 range. It is currently sitting right below the 200 day moving average and seems to be holding support there. I'm considering a stop loss just below $11 since this stock can move $0.83 a day with a trailing stop loss of 9%. I see it is valued under pressure of the VWAP that is currently at $12.20. This could be a beautiful continuation of the long trend that it has been in since January 2025 with an entry on this pullback. RSI looks like it is exhausting out with oversold conditions at 37.30. I like the inverted hammer that was placed and the fact that we have 3 days worth of support on the 200 day moving average.
On the fundamentals, this company is a cash king in the fact they have more cash than debt. Market Cap 567.26M vs. Enterprise Value 420.76M and Insider ownership is key: Insider Ownership: 22.58%. All of which show that management are in charge and have a vision.
As always, do your own research and due diligence. Not trading advice.
KALV Stock -12/9/2022-• Trend is technically bullish, prices contained in an ascending channel
• Bulls need to clear first resistance at 17 before prices can resume the rally
• Second stiff resistance is at 20
• As highlighted on the chart, 20 level was acting as a resistance in late 2020 and turned into support in 2021 after being breached
• 20 figure needs to be cleared successfully before we can see significant rally
$KALV Reports Positive Results for KVD900 Phase 2$KALV KalVista Pharmaceuticals Reports Positive Results for KVD900 Phase 2 Demonstrating Statistically and Clinically Significant Responses Across All Endpoints as an Oral On-Demand Treatment for HAE Attacks
– Oral KVD900 Primary Endpoint Shows Only 15% Use of Rescue Medication in Patients with Hereditary Angioedema (HAE) –
– KVD900 Generally Safe and Well-Tolerated –
There were no serious adverse events reported in the trial and no patients withdrew due to adverse events.
finance.yahoo.com
Potential Bearish Butterfly setting up in Kalvista$Kalv setting up for a potential Bearish Butterfly
But it's still early to say for sure !!!
PRZ will be 9.33
I expect only to see T1 (8.28) happening due to - a completion of the pattern will break an important resistance line going way back. That could send the price of this stock very high. (Gaps to be closed).
T2 come in at 7.61
Time will show!
Best to your trading!
WallStScalper.com
P.S Prior of posting this pattern I made a chart with a pattern showing a truncated B to C-leg - in what I called a potential Bearish Cypher. In lack of a name of this pattern which I often see in all trading categories - I called it a Bearish Cypher pattern. See chart below
The truncation of the B to C-leg makes it perhaps more suitable calling it a double bottom B to C-leg. It has the characteristics of always surpass the recent low (X to A leg) a little further than the X to A leg due to the natures of the B to C-leg taking stops out that have been place right under the X to A leg endpoint.
Perhaps it's better calling it a Bearish truncated Cypher Pattern. Anyway for your future trading - be aware of this truncation in the pattern that will give you an edge in trading harmonic patterns.
Lastly: There is nothing to prevent a full pattern happening either.
Showed visuel.:
A potential bearish shark is moving in on $Kalv istaPRZ at 9.76
Target 1: 8.40ish
Target 2: 7.59ish
Have to take out the 8.50 handle for this pattern to play out.
We'll trade this pattern long to the PRZ zone being montering it and then trade it down for the target mentioned above.
$KALV is about to get in geometry balance This biotech company shows all indications on going higher. Just got above EMA100 on daily. Fighting at a 78.6 fib line right now and should get convinced in going higher. Building support level here at the 8+ handle. Daily indicators fighting to get "locked in" to overbought condition.
Stay Sharp on charts!
WALLSTScalper.com